Skip to content
California Healthline California Healthline California Healthline
  • Republish Our Content
  • Email Sign Up
  • Contact Us
  • Connect With Us:
  • Contact
  • Twitter
  • Facebook
  • RSS
  • Daily Edition
  • Special Reports
    • Homeless Crisis
    • Medi-Cal Makeover
    • Industry Influence
    • Public Health Watch
  • Faces of Medi-Cal
  • Noticias En Español
  • More Topics
    • Aging
    • Asking Never Hurts
    • Audio Report
    • Covid
    • Health Industry
    • Insurance
    • Medi-Cal
    • Medicare
    • Mental Health
    • Spotlight

Search Results

Filter Results

Reset filters
Date
Custom Date Range
Topic
Content Type

Showing 51-60 of 188 results for "Samantha Young"

Sort by
A woman in scrubs and a mask points to a slideshow display.

Listen: Teaching Teens to Reverse Overdoses, Taxes on Uninsured Californians, and More

By Heidi de Marco and Stephanie O'Neill Patison November 23, 2022

California Healthline journalists report on efforts to train teens to use the opioid overdose reversal drug naloxone, the state’s decision not to spend the tax penalty money from uninsured residents, Centene’s political contributions, and efforts to keep young kids on Medicaid for several years after birth.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Centene Gives Big as It Courts Contracts and Settles Accusations of Overbilling

December 15, 2022

California Attorney General Sues Drugmakers Over Inflated Insulin Prices

By Angela Hart and Samantha Young January 12, 2023

California Attorney General Rob Bonta is taking three major drugmakers and three distributors to court, alleging the companies illegally raised prices at the expense of diabetes patients.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Fiscal general de California demanda a farmacéuticas por “inflar” los precios de la insulina

By Angela Hart and Samantha Young January 12, 2023

En la demanda, Rob Bonta argumentó que los precios se han disparado y que algunos pacientes se han visto obligados a racionar sus medicamentos o renunciar por completo a comprar insulina.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
An Eli Lilly & Co. logo is seen on a box of insulin medication in this arranged photograph.

Eli Lilly Slashed Insulin Prices. This Starts a Race to the Bottom.

By Bram Sable-Smith and Samantha Young March 2, 2023

Eli Lilly’s news that it plans to cut insulin costs for patients will help, not hinder, the recent efforts in California and by entrepreneurs such as Mark Cuban to offer lower-cost alternatives, drug pricing experts said.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Johanna and Trenerry are seen sitting next to one another in front of a table, posing for a photo together. The two are dressed for a wedding.

After the Pandemic Hit Nursing Homes Hard, Lawmakers Push to Tighten Licensing Rules

By Samantha Young May 13, 2022

Legislators are proposing an overhaul of California’s licensing system for nursing homes that would make it the most stringent in the country. They argue that disreputable and unlicensed owners and operators have harmed residents. The industry describes the proposed requirements as excessive.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
A photo shows Gavin Newsom outside speaking on a sunny day.

California’s Resolve Questioned After It Grants Medi-Cal Contract Concessions

By Bernard J. Wolfson and Samantha Young January 26, 2023

After the Department of Health Care Services canceled Medi-Cal contract awards under pressure from major insurers, some consumer advocates question the administration’s willpower to improve care in the safety-net program.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
In this photo illustration the Centene Corporation logo of an insurance company is seen on a smartphone and a pc screen.

California Handed Its Medicaid Drug Program to One Company. Then Came a Corporate Takeover.

By Samantha Young April 7, 2022

The company awarded the state’s Medi-Cal Rx contract was taken over by another company, Centene. That left the state with a contractor it didn’t pick — one that has been accused of overbilling nine other state Medicaid programs and is now under investigation by California.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Centene Agrees to Pay Massachusetts $14 Million Over Medicaid Prescription Claims

By Andy Miller and Samantha Young September 29, 2022

Massachusetts is the latest state to settle with St. Louis-based Centene Corp. over allegations that it overcharged Medicaid prescription drug programs.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
A photo shows a judge's gavel resting on a surface surrounded by shadows.

Centene to Pay $166 Million to Texas in Medicaid Drug Pricing Settlement

By Andy Miller and Samantha Young September 19, 2022

Texas is at least the 12th state to settle with St. Louis-based Centene Corp. over allegations that it overcharged Medicaid prescription drug programs.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
  • Previous
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next

From The California Health Care Foundation

Insurance Data Health Insurers Enrollment Almanac — 2025 Edition

The latest data shows that California health insurers covered 36.2 million people. See a breakdown of enrollment by regulator, market, and insurer, and access historical data.

The Latest on CalAIM Reforms

CalAIM has the potential to improve health outcomes for millions of people enrolled in Medi-Cal. Track the latest developments and insights on this multi-year reform effort.

Behavioral Health California's Behavioral Health Data Landscape

As the state embarks on a significant overhaul, this report captures the current state of behavioral health data collection. See how it currently measures quality and outcomes, as well as future directions for the system.

California Healthline

© California Healthline 1998-2025. All Rights Reserved.

California Healthline is a service of the California Health Care Foundation produced by KFF Health News, an editorially independent program of the KFF.

  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Staff
  • Republish Our Content
  • Email Sign-Up
  • Twitter
  • Facebook
  • RSS

Powered by WordPress VIP